Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, James J, Air GM, Capra JD, Ahmed R, Wilson PC.

Nature. 2008 May 29;453(7195):667-71. doi: 10.1038/nature06890. Epub 2008 Apr 30.

2.

Plasmablast-derived polyclonal antibody response after influenza vaccination.

He XS, Sasaki S, Narvaez CF, Zhang C, Liu H, Woo JC, Kemble GW, Dekker CL, Davis MM, Greenberg HB.

J Immunol Methods. 2011 Feb 28;365(1-2):67-75. doi: 10.1016/j.jim.2010.12.008. Epub 2010 Dec 21.

3.

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J.

PLoS One. 2008;3(12):e3942. doi: 10.1371/journal.pone.0003942. Epub 2008 Dec 16.

4.

Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.

Loebermann M, Voss U, Meyer S, Bosse D, Fritzsche C, Klammt S, Frimmel S, Riebold D, Reisinger EC.

PLoS One. 2013 Aug 16;8(8):e70866. doi: 10.1371/journal.pone.0070866. eCollection 2013.

5.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948
6.

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.

Pediatrics. 2006 Sep;118(3):e579-85.

PMID:
16950949
7.

Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination.

Gulati U, Keitel WA, Air GM.

Influenza Other Respir Viruses. 2007 Jul;1(4):147-56. doi: 10.1111/j.1750-2659.2007.00017.x.

8.

Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors.

Kubota-Koketsu R, Mizuta H, Oshita M, Ideno S, Yunoki M, Kuhara M, Yamamoto N, Okuno Y, Ikuta K.

Biochem Biophys Res Commun. 2009 Sep 11;387(1):180-5. doi: 10.1016/j.bbrc.2009.06.151. Epub 2009 Jul 4.

PMID:
19580789
9.

High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination.

Tan YC, Blum LK, Kongpachith S, Ju CH, Cai X, Lindstrom TM, Sokolove J, Robinson WH.

Clin Immunol. 2014 Mar;151(1):55-65. doi: 10.1016/j.clim.2013.12.008. Epub 2014 Jan 9.

10.

Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.

Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J.

J Med Virol. 2007 Mar;79(3):320-5.

PMID:
17245715
11.

Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.

Ottóffy G, Horváth P, Muth L, Sólyom A, Garami M, Kovács G, Nyári T, Molnár D, Pauler G, Jankovics I.

Pediatr Blood Cancer. 2014 Jun;61(6):1013-6. doi: 10.1002/pbc.24893. Epub 2014 Jan 3.

PMID:
24395342
12.

Ex vivo analysis of human memory B lymphocytes specific for A and B influenza hemagglutinin by polychromatic flow-cytometry.

Bardelli M, Alleri L, Angiolini F, Buricchi F, Tavarini S, Sammicheli C, Nuti S, Degl'Innocenti E, Isnardi I, Fragapane E, Del Giudice G, Castellino F, Galli G.

PLoS One. 2013 Aug 15;8(8):e70620. doi: 10.1371/journal.pone.0070620. eCollection 2013.

13.

Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.

Yim K, Miles B, Zinsou R, Prince G, Boukhvalova M.

Vaccine. 2012 Feb 8;30(7):1291-6. doi: 10.1016/j.vaccine.2011.12.084. Epub 2011 Dec 30.

PMID:
22210139
14.

High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.

Andrews SF, Kaur K, Pauli NT, Huang M, Huang Y, Wilson PC.

J Virol. 2015 Mar;89(6):3308-17. doi: 10.1128/JVI.02871-14. Epub 2015 Jan 14.

15.

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

Wack A, Baudner BC, Hilbert AK, Manini I, Nuti S, Tavarini S, Scheffczik H, Ugozzoli M, Singh M, Kazzaz J, Montomoli E, Del Giudice G, Rappuoli R, O'Hagan DT.

Vaccine. 2008 Jan 24;26(4):552-61. Epub 2007 Dec 7.

PMID:
18162266
16.

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.

Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, Anandarajah AP, Looney RJ, Thiele RG, Anolik JH, Coca A, Wei C, Rosenberg AF, Feng C, Treanor JJ, Lee FE, Sanz I.

Arthritis Res Ther. 2011;13(6):R209. doi: 10.1186/ar3542. Epub 2011 Dec 16.

17.

Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination.

Choi YS, Baek YH, Kang W, Nam SJ, Lee J, You S, Chang DY, Youn JC, Choi YK, Shin EC.

Clin Vaccine Immunol. 2011 Sep;18(9):1519-23. doi: 10.1128/CVI.05053-11. Epub 2011 Aug 3.

18.

Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.

Cherukuri A, Servat E, Woo J.

Vaccine. 2012 Jan 5;30(2):237-46. doi: 10.1016/j.vaccine.2011.11.001. Epub 2011 Nov 12.

PMID:
22080173
19.

Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.

Ott U, Sauerbrei A, Lange J, Schäfler A, Walther M, Wolf G, Wutzler P, Zell R, Krumbholz A.

Med Microbiol Immunol. 2012 Aug;201(3):297-302. doi: 10.1007/s00430-012-0231-8. Epub 2012 Feb 17.

PMID:
22350187
20.

Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.

Gorse GJ, Falsey AR, Fling JA, Poling TL, Strout CB, Tsang PH.

Vaccine. 2013 May 1;31(19):2358-65. doi: 10.1016/j.vaccine.2013.03.008. Epub 2013 Mar 13.

PMID:
23499604
Items per page

Supplemental Content

Write to the Help Desk